MHCD:CA:TSX-Middlefield Healthcare Dividend ETF (CAD)

ETF | Others |

Last Closing

CAD 11.72

Change

-0.12 (-1.01)%

Market Cap

CAD 0.16B

Volume

1.32K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 4.83B
PHYS-U:CA Sprott Physical Gold Trust

+0.02 (+0.11%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

N/A

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+1.03 (+2.52%)

CAD 3.92B
XEQT:CA iShares Core Equity Portfolio

+0.06 (+0.19%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.25 (+2.49%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.12 (-0.55%)

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

+0.12 (+0.58%)

CAD 2.52B

ETFs Containing MHCD:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.33% 68% D+ 65% D
Dividend Return 0.47% 38% F 16% F
Total Return 9.79% 68% D+ 63% D
Trailing 12 Months  
Capital Gain 7.72% 50% F 54% F
Dividend Return 0.46% 33% F 11% F
Total Return 8.18% 48% F 46% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.54% 47% F 43% F
Dividend Return 0.56% 46% F 35% F
Total Return 0.02% 32% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 3.91% 80% B- 92% A
Risk Adjusted Return 14.28% 47% F 41% F
Market Capitalization 0.16B 75% C 45% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.